Regulation & Compliance

Bluejay Diagnostics can now make 9 million sepsis tests. This manufacturing win is huge, but the real race for FDA approval has only just begun.

In a strategic all-equity deal, JAPEX subsidiary Peoria Resources acquires 101,000 acres in Colorado, signaling a major pivot for the Japanese energy giant.

Fintech giant Mercury aims to become a fully regulated bank, a landmark move poised to reshape startup banking and challenge traditional finance.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

The latest VyOS release adds TLS for syslog, AWS GWLB support, and RPKI controls, boosting security and flexibility for modern network infrastructures.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

President Trump's order eases marijuana rules, but a new law threatens to dismantle the $28B hemp industry, creating unprecedented regulatory chaos.

Nuveen is combining three tax-free income funds. For investors, this means lower fees and stable payouts, but also new state tax implications.

A historic U.S. executive order reclassifies cannabis, opening the door for pharmaceutical products. One Canadian firm is already years ahead of the curve.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.

A Los Angeles jury found Johnson & Johnson liable for causing ovarian cancer, a landmark verdict that renews the company's legal battles over its talc products.

The software firm's payout over auto-renewal practices highlights the growing legal risks for subscription businesses under California's tough new laws.

A new national scholarship champions medical integrity, yet its founder recently settled a major False Claims Act case, raising complex questions.

An expert shares urgent year-end tips on charitable giving, portfolio rebalancing, and college savings to maximize benefits before new tax laws take effect.

As AI drives innovation, it also fuels a projected $10 trillion in cyber losses. Experts warn reactive security is failing and a proactive shift is vital.

A new report projects a staggering $47T cost from chronic illness by 2039. Experts say prevention and innovation could save trillions and 13.5M lives.

A $1.9M real estate deal for a Pennsylvania vet clinic reveals how UPREIT exchanges help practice owners unlock capital tax-efficiently while securing care.

As Leverage Shares by Themes launches seven new 2x daily leveraged ETFs, a look at the high-stakes game of amplified returns and the risks for investors.

Facing declining revenue, Cardlytics brings back former CFO David Evans, who led its 2018 IPO, in a strategic bet on experience for its next chapter.

With trial data showing an average 23% body weight loss, Novo Nordisk's new combination drug CagriSema could usher in a powerful new era for medicine.